Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Quantifying non-adherence to anti-tuberculosis treatment due to early discontinuation: a systematic literature review of timings to loss to follow-up.
Walker, EF; Flook, M; Rodger, AJ; FIELDING, KL; STAGG, HR;
2024
BMJ Open Respiratory Research, (2024).11 1 10.1136/bmjresp-2023-001894.
Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains.
PAINTER, H; WILLCOCKS, S; Zelmer, A; Reljic, R; Tanner, R; Fletcher, H;
2024
Tuberculosis (Edinburgh, Scotland), (2024).146, 10.1016/j.tube.2024.102494.
Community-based active-case finding for tuberculosis: navigating a complex minefield.
MacPherson, P; Shanaube, K; Phiri, MD; Rickman, HM; HORTON, KC; Feasey, HR A; CORBETT, EL; BURKE, RM; Rangaka, MX;
2024
BMC global and public health, (2024).2 1 10.1186/s44263-024-00042-9.
Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana.
MILBURN, J; Ntwayagae, O; Suresh, R; Ngoni, K; Northcott, C; Penney, J; Kinsella, M; Mechie, I; Ensor, S; Thamae, G; Leeme, T; LAWRENCE, DS; Chebani, T; GRINT, D; Tenforde, MW; Avalos, A; Ramaabya, D; Ogando, J; Mokomane, M; Mine, M; JARVIS, JN;
2024
Clinical infectious diseases, (2024).79 2 10.1093/cid/ciae066.
Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa.
SUMNER, T; CLARK, RA; Mukandavire, C; Portnoy, A; Weerasuriya, CK; Bakker, R; Scarponi, D; Hatherill, M; Menzies, NA; WHITE, RG;
2024
Vaccine, (2024).42 6 10.1016/j.vaccine.2024.01.072.
Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone.
Blankson, HN A; Kamara, RF; Barilar, I; Andres, S; Conteh, OS; Dallenga, T; Foray, L; Maurer, F; KRANZER, K; Utpatel, C; Niemann, S;
2024
Microbiology spectrum, (2024).12 3 10.1128/spectrum.02405-23.
Data supporting: "The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents: results of the POPVAC C randomised, controlled trial".
Nassuuna, J; ZIRIMENYA, L; NKURUNUNGI, G; Natukunda, A; WEBB, E; ELLIOTT, AM;
2024
, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2024). 10.17037/DATA.00003760.
Comparing disease specific catastrophic cost estimates using longitudinal and cross-sectional designs: The example of tuberculosis.
YAMANAKA, T; Castro, MC; Ferrer, JP; Cox, SE; Laurence, YV; VASSALL, A;
2024
Social Science & Medicine, (2024).344, 10.1016/j.socscimed.2024.116631.
Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines.
YAMANAKA, T; Castro, MC; Ferrer, JP; Solon, JA; Cox, SE; Laurence, YV; VASSALL, A;
2024
PloS one, (2024).19 1 10.1371/journal.pone.0297342.
What is next for BCG revaccination to prevent tuberculosis?.
WHITE, RG; Fiore-Gartland, AJ; Hanekom, WA; Vekemans, J; Garcia-Basteiro, AL; Churchyard, G; Rangaka, MX; Frick, M; Behr, MA; Hill, PC; Mave, V;
2024
The Lancet Respiratory medicine, (2024).12 3 10.1016/S2213-2600(24)00009-2.